25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Green Cross Lab Cell Corporation
Buy, Hold or Sell?

Let's analyze Green Cross Lab Cell Corporation together

I guess you are interested in Green Cross Lab Cell Corporation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Green Cross Lab Cell Corporation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Green Cross Lab Cell Corporation

I send you an email if I find something interesting about Green Cross Lab Cell Corporation.

1. Quick Overview

1.1. Quick analysis of Green Cross Lab Cell Corporation (30 sec.)










1.2. What can you expect buying and holding a share of Green Cross Lab Cell Corporation? (30 sec.)

How much money do you get?

How much money do you get?
₩0.00
When do you have the money?
1 year
How often do you get paid?
65.5%

What is your share worth?

Current worth
₩34,943.51
Expected worth in 1 year
₩34,614.88
How sure are you?
62.1%

+ What do you gain per year?

Total Gains per Share
₩-328.63
Return On Investment
-1.3%

For what price can you sell your share?

Current Price per Share
₩25,800.00
Expected price per share
₩0 - ₩30,900
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Green Cross Lab Cell Corporation (5 min.)




Live pricePrice per Share (EOD)
₩25,800.00

2.2. Growth of Green Cross Lab Cell Corporation (5 min.)




Is Green Cross Lab Cell Corporation growing?

Current yearPrevious yearGrowGrow %
How rich?$367.5m$376.2m-$2m-0.5%

How much money is Green Cross Lab Cell Corporation making?

Current yearPrevious yearGrowGrow %
Making money-$1.8m-$1.5m-$342.2k-18.3%
Net Profit Margin-6.6%-5.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Green Cross Lab Cell Corporation (5 min.)




2.4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  

3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Green Cross Lab Cell Corporation?

Welcome investor! Green Cross Lab Cell Corporation's management wants to use your money to grow the business. In return you get a share of Green Cross Lab Cell Corporation.

First you should know what it really means to hold a share of Green Cross Lab Cell Corporation. And how you can make/lose money.

Speculation

The Price per Share of Green Cross Lab Cell Corporation is ₩25,800. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Green Cross Lab Cell Corporation.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Green Cross Lab Cell Corporation, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is ₩34,943.51. Based on the TTM, the Book Value Change Per Share is ₩-82.16 per quarter. Based on the YOY, the Book Value Change Per Share is ₩-169.39 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is ₩0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Green Cross Lab Cell Corporation.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.290.0%-0.120.0%-0.090.0%0.110.0%0.070.0%
Usd Book Value Change Per Share-0.260.0%-0.060.0%-0.120.0%1.110.0%0.840.0%
Usd Dividend Per Share0.000.0%0.000.0%0.060.0%0.030.0%0.030.0%
Usd Total Gains Per Share-0.260.0%-0.060.0%-0.060.0%1.150.0%0.870.0%
Usd Price Per Share19.74-26.09-30.49-40.41-37.36-
Price to Earnings Ratio-17.18-23.74--27.37-3.45--724.71-
Price-to-Total Gains Ratio-74.96-500.52-22.88-419.36--3,131.94-
Price to Book Ratio0.81-1.05-1.22-9.77-10.99-
Price-to-Total Gains Ratio-74.96-500.52-22.88-419.36--3,131.94-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share18.06
Number of shares55
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.03
Usd Book Value Change Per Share-0.061.11
Usd Total Gains Per Share-0.061.15
Gains per Quarter (55 shares)-3.1663.04
Gains per Year (55 shares)-12.65252.17
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-13-237245242
20-25-3614490494
30-38-4921736746
40-51-6228981998
50-63-753512261250
60-76-884214711502
70-89-1014917161754
80-101-1145619612006
90-114-1276322072258
100-127-1407024522510

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share2.02.00.050.0%7.05.00.058.3%12.08.00.060.0%17.012.00.058.6%17.012.00.058.6%
Book Value Change Per Share2.02.00.050.0%7.05.00.058.3%11.09.00.055.0%15.014.00.051.7%15.014.00.051.7%
Dividend per Share0.00.04.00.0%3.00.09.025.0%11.00.09.055.0%19.00.010.065.5%19.00.010.065.5%
Total Gains per Share2.02.00.050.0%8.04.00.066.7%14.06.00.070.0%18.011.00.062.1%18.011.00.062.1%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Green Cross Lab Cell Corporation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---376.195-82.157-78%-169.389-55%1592.089-124%1204.948-131%
Book Value Per Share--34943.50535577.202-2%35771.495-2%21016.515+66%15484.689+126%
Current Ratio--0.7770.855-9%1.031-25%1.462-47%2.951-74%
Debt To Asset Ratio--0.2010.190+6%0.196+2%0.289-31%0.258-22%
Debt To Equity Ratio--0.2540.238+7%0.244+4%0.449-43%0.385-34%
Dividend Per Share----0%87.414-100%45.401-100%35.912-100%
Eps---410.464-178.153-57%-135.340-67%151.134-372%105.444-489%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Market Cap387699180000.000-9%423764220000.000560135152500.000-24%654430205000.000-35%867552050750.000-51%801980781724.138-47%
Net Profit Margin---0.136-0.066-51%-0.050-63%0.033-513%0.024-673%
Operating Margin----0%0.014-100%0.018-100%0.012-100%
Operating Ratio--1.5431.711-10%1.335+16%1.117+38%1.320+17%
Pb Ratio0.738-9%0.8071.047-23%1.217-34%9.774-92%10.992-93%
Pe Ratio-15.714+9%-17.17623.738-172%-27.367+59%3.449-598%-724.714+4119%
Price Per Share25800.000-9%28200.00037275.000-24%43550.000-35%57732.500-51%53368.966-47%
Price To Free Cash Flow Ratio----9.8820%31.482-100%-58.1800%-2.9940%
Price To Total Gains Ratio-68.581+9%-74.961500.520-115%22.885-428%419.365-118%-3131.937+4078%
Quick Ratio---0.333-100%0.872-100%1.263-100%1.666-100%
Return On Assets---0.009-0.004-57%-0.003-65%0.010-192%0.007-227%
Return On Equity---0.012-0.005-56%-0.004-65%0.018-166%0.013-193%
Total Gains Per Share---376.195-82.157-78%-81.974-78%1637.489-123%1240.861-130%
Usd Book Value--367569681.500374235520.596-2%376279280.725-2%221072088.229+66%162882981.258+126%
Usd Book Value Change Per Share---0.263-0.058-78%-0.119-55%1.114-124%0.843-131%
Usd Book Value Per Share--24.46024.904-2%25.040-2%14.712+66%10.839+126%
Usd Dividend Per Share----0%0.061-100%0.032-100%0.025-100%
Usd Eps---0.287-0.125-57%-0.095-67%0.106-372%0.074-489%
Usd Free Cash Flow----1038481.2180%-1481822.1480%1912374.057-100%1129077.100-100%
Usd Market Cap271389426.000-9%296634954.000392094606.750-24%458101143.500-35%607286435.525-51%561386547.207-47%
Usd Price Per Share18.060-9%19.74026.093-24%30.485-35%40.413-51%37.358-47%
Usd Profit---4317662.300-1873985.649-57%-1531780.404-65%1489585.806-390%1039999.422-515%
Usd Revenue--31784314.80032277642.549-2%32583593.214-2%27810625.177+14%21916839.212+45%
Usd Total Gains Per Share---0.263-0.058-78%-0.057-78%1.146-123%0.869-130%
 EOD+3 -4MRQTTM+4 -22YOY+3 -275Y+9 -2110Y+9 -21

3.3 Fundamental Score

Let's check the fundamental score of Green Cross Lab Cell Corporation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-15.714
Price to Book Ratio (EOD)Between0-10.738
Net Profit Margin (MRQ)Greater than0-0.136
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.000
Current Ratio (MRQ)Greater than10.777
Debt to Asset Ratio (MRQ)Less than10.201
Debt to Equity Ratio (MRQ)Less than10.254
Return on Equity (MRQ)Greater than0.15-0.012
Return on Assets (MRQ)Greater than0.05-0.009
Total3/10 (30.0%)

3.4 Technical Score

Let's check the technical score of Green Cross Lab Cell Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.381
Ma 20Greater thanMa 5029,290.000
Ma 50Greater thanMa 10031,993.000
Ma 100Greater thanMa 20032,067.000
OpenGreater thanClose25,500.000
Total0/5 (0.0%)

4. In-depth Analysis

4.1 About Green Cross Lab Cell Corporation

GC Cell Corporation develops cell therapy products. It also provides cell banking, sample inspection, clinical trial, and bio logistics services. Its main product is Immuncell-LC. GC Cell Corporation has strategic agreement with Lukas Biomedical Co., Ltd. to develop Cell therapy. The company was formerly known as Green Cross Lab Cell Corporation and changed its name to GC Cell Corporation in November 2021. GC Cell Corporation was founded in 2011 and is based in Yongin-si, South Korea.

Fundamental data was last updated by Penke on 2024-11-19 05:05:05.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just not able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Green Cross Lab Cell Corporation earns for each ₩1 of revenue.

  • Above 10% is considered healthy but always compare Green Cross Lab Cell Corporation to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -13.6% means that ₩-0.14 for each ₩1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Green Cross Lab Cell Corporation:

  • The MRQ is -13.6%. The company is making a huge loss. -2
  • The TTM is -6.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-13.6%TTM-6.6%-7.0%
TTM-6.6%YOY-5.0%-1.6%
TTM-6.6%5Y3.3%-9.9%
5Y3.3%10Y2.4%+0.9%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-13.6%-5.6%-8.0%
TTM-6.6%-8.8%+2.2%
YOY-5.0%-0.8%-4.2%
5Y3.3%-1.9%+5.2%
10Y2.4%-0.5%+2.9%
4.3.1.2. Return on Assets

Shows how efficient Green Cross Lab Cell Corporation is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Green Cross Lab Cell Corporation to the Diagnostics & Research industry mean.
  • -0.9% Return on Assets means that Green Cross Lab Cell Corporation generated ₩-0.01 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Green Cross Lab Cell Corporation:

  • The MRQ is -0.9%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -0.4%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-0.9%TTM-0.4%-0.5%
TTM-0.4%YOY-0.3%-0.1%
TTM-0.4%5Y1.0%-1.4%
5Y1.0%10Y0.7%+0.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-0.9%-1.2%+0.3%
TTM-0.4%-2.1%+1.7%
YOY-0.3%-0.9%+0.6%
5Y1.0%-0.1%+1.1%
10Y0.7%-0.5%+1.2%
4.3.1.3. Return on Equity

Shows how efficient Green Cross Lab Cell Corporation is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Green Cross Lab Cell Corporation to the Diagnostics & Research industry mean.
  • -1.2% Return on Equity means Green Cross Lab Cell Corporation generated ₩-0.01 for each ₩1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Green Cross Lab Cell Corporation:

  • The MRQ is -1.2%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -0.5%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.2%TTM-0.5%-0.7%
TTM-0.5%YOY-0.4%-0.1%
TTM-0.5%5Y1.8%-2.3%
5Y1.8%10Y1.3%+0.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.2%-0.5%-0.7%
TTM-0.5%-1.7%+1.2%
YOY-0.4%0.3%-0.7%
5Y1.8%-0.9%+2.7%
10Y1.3%-0.9%+2.2%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Green Cross Lab Cell Corporation.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Green Cross Lab Cell Corporation is operating .

  • Measures how much profit Green Cross Lab Cell Corporation makes for each ₩1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Green Cross Lab Cell Corporation to the Diagnostics & Research industry mean.
  • An Operating Margin of 0.0% means the company generated ₩0.00  for each ₩1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Green Cross Lab Cell Corporation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY1.4%-1.4%
TTM-5Y1.8%-1.8%
5Y1.8%10Y1.2%+0.7%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--9.7%+9.7%
TTM--12.8%+12.8%
YOY1.4%3.3%-1.9%
5Y1.8%0.5%+1.3%
10Y1.2%3.1%-1.9%
4.3.2.2. Operating Ratio

Measures how efficient Green Cross Lab Cell Corporation is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 1.54 means that the operating costs are ₩1.54 for each ₩1 in net sales.

Let's take a look of the Operating Ratio trends of Green Cross Lab Cell Corporation:

  • The MRQ is 1.543. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.711. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.543TTM1.711-0.168
TTM1.711YOY1.335+0.376
TTM1.7115Y1.117+0.594
5Y1.11710Y1.320-0.203
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5431.254+0.289
TTM1.7111.284+0.427
YOY1.3351.266+0.069
5Y1.1171.208-0.091
10Y1.3201.191+0.129
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Green Cross Lab Cell Corporation.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Green Cross Lab Cell Corporation is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 0.78 means the company has ₩0.78 in assets for each ₩1 in short-term debts.

Let's take a look of the Current Ratio trends of Green Cross Lab Cell Corporation:

  • The MRQ is 0.777. The company is just not able to pay all its short-term debts. -1
  • The TTM is 0.855. The company is just not able to pay all its short-term debts. -1
Trends
Current periodCompared to+/- 
MRQ0.777TTM0.855-0.078
TTM0.855YOY1.031-0.176
TTM0.8555Y1.462-0.608
5Y1.46210Y2.951-1.489
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7772.028-1.251
TTM0.8552.113-1.258
YOY1.0312.555-1.524
5Y1.4622.668-1.206
10Y2.9513.229-0.278
4.4.3.2. Quick Ratio

Measures if Green Cross Lab Cell Corporation is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Green Cross Lab Cell Corporation to the Diagnostics & Research industry mean.
  • A Quick Ratio of 0.00 means the company can pay off ₩0.00 for each ₩1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Green Cross Lab Cell Corporation:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM0.333-0.333
TTM0.333YOY0.872-0.539
TTM0.3335Y1.263-0.929
5Y1.26310Y1.666-0.403
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.228-1.228
TTM0.3331.241-0.908
YOY0.8721.803-0.931
5Y1.2632.100-0.837
10Y1.6662.435-0.769
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Green Cross Lab Cell Corporation.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Green Cross Lab Cell Corporation assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Green Cross Lab Cell Corporation to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.20 means that Green Cross Lab Cell Corporation assets are financed with 20.1% credit (debt) and the remaining percentage (100% - 20.1%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Green Cross Lab Cell Corporation:

  • The MRQ is 0.201. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.190. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.201TTM0.190+0.011
TTM0.190YOY0.196-0.006
TTM0.1905Y0.289-0.099
5Y0.28910Y0.258+0.031
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2010.437-0.236
TTM0.1900.440-0.250
YOY0.1960.359-0.163
5Y0.2890.428-0.139
10Y0.2580.450-0.192
4.5.4.2. Debt to Equity Ratio

Measures if Green Cross Lab Cell Corporation is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Green Cross Lab Cell Corporation to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 25.4% means that company has ₩0.25 debt for each ₩1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Green Cross Lab Cell Corporation:

  • The MRQ is 0.254. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.238. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.254TTM0.238+0.016
TTM0.238YOY0.244-0.007
TTM0.2385Y0.449-0.212
5Y0.44910Y0.385+0.065
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.2540.640-0.386
TTM0.2380.686-0.448
YOY0.2440.502-0.258
5Y0.4490.666-0.217
10Y0.3850.712-0.327
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₩1 in earnings Green Cross Lab Cell Corporation generates.

  • Above 15 is considered overpriced but always compare Green Cross Lab Cell Corporation to the Diagnostics & Research industry mean.
  • A PE ratio of -17.18 means the investor is paying ₩-17.18 for every ₩1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Green Cross Lab Cell Corporation:

  • The EOD is -15.714. Based on the earnings, the company is expensive. -2
  • The MRQ is -17.176. Based on the earnings, the company is expensive. -2
  • The TTM is 23.738. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD-15.714MRQ-17.176+1.462
MRQ-17.176TTM23.738-40.913
TTM23.738YOY-27.367+51.104
TTM23.7385Y3.449+20.289
5Y3.44910Y-724.714+728.162
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-15.714-0.407-15.307
MRQ-17.176-0.693-16.483
TTM23.738-0.881+24.619
YOY-27.367-0.145-27.222
5Y3.4491.937+1.512
10Y-724.7143.729-728.443
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Green Cross Lab Cell Corporation:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-9.882+9.882
TTM-9.882YOY31.482-41.364
TTM-9.8825Y-58.180+48.298
5Y-58.18010Y-2.994-55.185
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ--1.060+1.060
TTM-9.882-1.123-8.759
YOY31.482-2.356+33.838
5Y-58.180-2.367-55.813
10Y-2.994-2.248-0.746
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Green Cross Lab Cell Corporation is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 0.81 means the investor is paying ₩0.81 for each ₩1 in book value.

Let's take a look of the Price to Book Ratio trends of Green Cross Lab Cell Corporation:

  • The EOD is 0.738. Based on the equity, the company is cheap. +2
  • The MRQ is 0.807. Based on the equity, the company is cheap. +2
  • The TTM is 1.047. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD0.738MRQ0.807-0.069
MRQ0.807TTM1.047-0.240
TTM1.047YOY1.217-0.170
TTM1.0475Y9.774-8.727
5Y9.77410Y10.992-1.218
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD0.7382.297-1.559
MRQ0.8072.330-1.523
TTM1.0472.320-1.273
YOY1.2172.384-1.167
5Y9.7743.753+6.021
10Y10.9924.539+6.453
4.6.2. Total Gains per Share
3rd party ad coffee SUPPORTERis ad-free.

6. Financial Statements




6.1. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in KRW. All numbers in thousands.

Summary
Total Assets656,871,411
Total Liabilities131,771,866
Total Stockholder Equity518,275,877
 As reported
Total Liabilities 131,771,866
Total Stockholder Equity+ 518,275,877
Total Assets = 656,871,411

Assets

Total Assets656,871,411
Total Current Assets66,818,333
Long-term Assets590,053,077
Total Current Assets
Total Current Assets  (as reported)66,818,333
Total Current Assets  (calculated)0
+/- 66,818,333
Long-term Assets
Long-term Assets  (as reported)590,053,077
Long-term Assets  (calculated)0
+/- 590,053,077

Liabilities & Shareholders' Equity

Total Current Liabilities86,023,625
Long-term Liabilities45,748,241
Total Stockholder Equity518,275,877
Total Current Liabilities
Total Current Liabilities  (as reported)86,023,625
Total Current Liabilities  (calculated)0
+/- 86,023,625
Long-term Liabilities
Long-term Liabilities  (as reported)45,748,241
Long-term Liabilities  (calculated)0
+/- 45,748,241
Total Stockholder Equity
Total Stockholder Equity (as reported)518,275,877
Total Stockholder Equity (calculated)0
+/- 518,275,877
Other
Common Stock Shares Outstanding 15,023
Net Invested Capital 518,275,877
Net Working Capital -19,205,292



6.2. Balance Sheets Structured

Currency in KRW. All numbers in thousands.

 Trend2024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-30
> Total Assets 
56,161,895
57,212,911
55,355,541
56,107,791
60,119,671
63,913,172
57,268,066
63,881,561
65,197,624
69,573,418
68,064,636
67,016,287
71,066,332
73,352,588
76,362,722
103,030,387
109,478,729
118,095,915
645,574,518
678,550,146
675,829,707
681,718,881
676,530,629
664,991,417
652,326,519
655,839,679
665,173,377
661,905,750
656,871,411
656,871,411661,905,750665,173,377655,839,679652,326,519664,991,417676,530,629681,718,881675,829,707678,550,146645,574,518118,095,915109,478,729103,030,38776,362,72273,352,58871,066,33267,016,28768,064,63669,573,41865,197,62463,881,56157,268,06663,913,17260,119,67156,107,79155,355,54157,212,91156,161,895
   > Total Current Assets 
44,774,361
45,651,041
44,116,086
44,398,614
45,878,278
43,599,345
36,017,759
31,411,735
32,015,335
34,583,462
22,865,564
20,739,000
22,659,233
26,463,954
25,875,472
39,452,822
52,063,357
58,729,686
96,842,176
128,938,950
95,345,126
103,288,800
93,326,481
76,611,688
65,614,660
67,936,772
63,887,519
67,032,846
66,818,333
66,818,33367,032,84663,887,51967,936,77265,614,66076,611,68893,326,481103,288,80095,345,126128,938,95096,842,17658,729,68652,063,35739,452,82225,875,47226,463,95422,659,23320,739,00022,865,56434,583,46232,015,33531,411,73536,017,75943,599,34545,878,27844,398,61444,116,08645,651,04144,774,361
       Cash And Cash Equivalents 
147,442
173,554
38,583,533
38,397,506
33,892,197
31,780,226
23,284,740
17,877,549
18,235,159
19,945,608
13,589,561
10,905,961
10,956,788
14,421,348
9,113,495
14,372,418
6,935
10,763
0
1,220
7,710
11,111
47,374,244
3,713
420
19,423,604
12,557,663
13,352,288
0
013,352,28812,557,66319,423,6044203,71347,374,24411,1117,7101,220010,7636,93514,372,4189,113,49514,421,34810,956,78810,905,96113,589,56119,945,60818,235,15917,877,54923,284,74031,780,22633,892,19738,397,50638,583,533173,554147,442
       Short-term Investments 
39,561,440
40,172,505
0
0
0
0
0
0
0
0
0
0
0
0
3,000,000
2,000,000
1,000,000
500,000
2,005,170
0
0
0
0
0
0
0
0
0
0
00000000002,005,170500,0001,000,0002,000,0003,000,00000000000000040,172,50539,561,440
       Net Receivables 
4,586,366
5,014,811
5,251,008
5,251,218
6,043,149
5,582,334
6,385,013
5,782,750
6,602,308
6,610,245
7,423,797
7,449,712
9,589,812
10,401,435
12,438,254
21,569,808
18,906,919
27,117,377
61,644,734
71,289,335
39,748,755
48,521,530
33,345,861
31,071,234
31,405,805
33,928,271
32,674,254
33,861,446
0
033,861,44632,674,25433,928,27131,405,80531,071,23433,345,86148,521,53039,748,75571,289,33561,644,73427,117,37718,906,91921,569,80812,438,25410,401,4359,589,8127,449,7127,423,7976,610,2456,602,3085,782,7506,385,0135,582,3346,043,1495,251,2185,251,0085,014,8114,586,366
       Other Current Assets 
432,420
153,201
177,152
373,888
378,126
368,026
517,684
504,329
356,606
111,439
157,509
634,670
682,796
620,914
768,048
1,027,449
948,188
842,817
6,048,131
942,808
1,259,675
1,621,284
3,125,119
2,322,836
3,749,140
603,436
593,205
550,725
0
0550,725593,205603,4363,749,1402,322,8363,125,1191,621,2841,259,675942,8086,048,131842,817948,1881,027,449768,048620,914682,796634,670157,509111,439356,606504,329517,684368,026378,126373,888177,152153,201432,420
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
583,204,148
588,379,729
586,711,858
587,902,907
601,285,857
594,872,904
590,053,077
590,053,077594,872,904601,285,857587,902,907586,711,858588,379,729583,204,1480000000000000000000000
       Property Plant Equipment 
3,697,471
3,637,277
3,729,678
3,972,376
5,517,368
7,493,518
8,353,282
16,309,844
16,532,318
16,923,279
20,990,266
18,721,528
18,695,734
18,542,691
19,862,526
23,298,955
25,558,158
26,684,844
113,354,767
116,207,114
119,493,304
118,062,752
119,170,808
123,513,583
125,598,457
123,532,915
125,465,382
123,688,049
0
0123,688,049125,465,382123,532,915125,598,457123,513,583119,170,808118,062,752119,493,304116,207,114113,354,76726,684,84425,558,15823,298,95519,862,52618,542,69118,695,73418,721,52820,990,26616,923,27916,532,31816,309,8448,353,2827,493,5185,517,3683,972,3763,729,6783,637,2773,697,471
       Goodwill 
1,017,000
1,017,000
248,000
248,000
248,000
248,000
248,000
248,000
248,000
708,000
460,000
460,000
460,000
460,000
460,000
460,000
460,000
460,000
378,642,616
378,642,616
378,642,616
378,642,616
378,642,616
378,642,616
378,642,616
378,642,616
378,642,616
378,642,616
0
0378,642,616378,642,616378,642,616378,642,616378,642,616378,642,616378,642,616378,642,616378,642,616378,642,616460,000460,000460,000460,000460,000460,000460,000460,000708,000248,000248,000248,000248,000248,000248,000248,0001,017,0001,017,000
       Long Term Investments 
501,500
501,500
501,500
501,500
501,500
501,500
501,500
3,264,259
3,267,097
3,265,542
8,667,931
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0000000000000000008,667,9313,265,5423,267,0973,264,259501,500501,500501,500501,500501,500501,500501,500
       Intangible Assets 
1,112,515
1,392,126
1,388,023
1,480,565
2,579,650
2,580,934
2,565,169
2,790,426
2,637,705
2,594,930
2,954,498
3,730,336
3,749,795
3,839,818
4,472,551
4,680,793
5,292,486
6,077,514
25,799,435
25,702,709
27,655,628
27,618,782
29,893,759
32,656,732
32,818,153
33,869,331
34,182,647
34,914,203
0
034,914,20334,182,64733,869,33132,818,15332,656,73229,893,75927,618,78227,655,62825,702,70925,799,4356,077,5145,292,4864,680,7934,472,5513,839,8183,749,7953,730,3362,954,4982,594,9302,637,7052,790,4262,565,1692,580,9342,579,6501,480,5651,388,0231,392,1261,112,515
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-1
1
0
0
0
0
0
000001-10000000000000000000000
> Total Liabilities 
7,393,917
8,181,434
7,032,093
8,322,831
11,396,881
15,674,235
9,546,672
17,418,692
18,587,632
23,249,260
24,015,394
23,465,747
25,099,777
26,095,155
29,192,719
51,517,706
56,332,103
56,460,442
134,571,031
142,696,550
135,610,131
132,015,380
138,072,401
133,023,728
122,288,618
114,684,955
123,691,620
131,153,087
131,771,866
131,771,866131,153,087123,691,620114,684,955122,288,618133,023,728138,072,401132,015,380135,610,131142,696,550134,571,03156,460,44256,332,10351,517,70629,192,71926,095,15525,099,77723,465,74724,015,39423,249,26018,587,63217,418,6929,546,67215,674,23511,396,8818,322,8317,032,0938,181,4347,393,917
   > Total Current Liabilities 
4,881,891
5,292,342
4,574,530
5,533,592
8,249,957
12,164,717
7,220,163
8,915,840
9,988,866
10,500,606
12,921,610
10,250,248
11,569,261
12,367,297
17,069,990
24,140,790
28,251,667
29,695,363
84,041,719
95,723,099
91,050,925
83,831,384
88,115,471
82,847,276
72,266,295
66,614,192
76,816,032
84,843,241
86,023,625
86,023,62584,843,24176,816,03266,614,19272,266,29582,847,27688,115,47183,831,38491,050,92595,723,09984,041,71929,695,36328,251,66724,140,79017,069,99012,367,29711,569,26110,250,24812,921,61010,500,6069,988,8668,915,8407,220,16312,164,7178,249,9575,533,5924,574,5305,292,3424,881,891
       Short-term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
31,000,000
31,400,000
33,511,000
30,000,000
35,000,000
35,000,000
39,000,000
0
0
0
0
000039,000,00035,000,00035,000,00030,000,00033,511,00031,400,00031,000,000000000000000000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
40,000,000
40,000,000
39,608,000
34,608,000
44,608,000
54,208,000
0
054,208,00044,608,00034,608,00039,608,00040,000,00040,000,0000000000000000000000000
       Accounts payable 
204,275
375,713
227,340
481,695
704,977
604,401
798,273
998,018
1,115,695
881,927
1,077,372
901,431
601,815
1,414,377
730,871
718,225
0
0
0
0
2,616,464
3,403,463
4,319,496
2,909,070
3,139,411
3,093,524
3,038,042
2,367,061
0
02,367,0613,038,0423,093,5243,139,4112,909,0704,319,4963,403,4632,616,4640000718,225730,8711,414,377601,815901,4311,077,372881,9271,115,695998,018798,273604,401704,977481,695227,340375,713204,275
       Other Current Liabilities 
2,083,220
2,111,350
1,834,925
2,292,073
4,331,927
6,954,589
2,680,433
2,048,870
2,165,366
3,704,726
4,474,382
2,681,676
3,237,850
3,225,607
5,328,064
12,461,438
0
0
0
0
23,677,179
19,091,043
22,395,663
-1
-1
0
-1
0
0
00-10-1-122,395,66319,091,04323,677,179000012,461,4385,328,0643,225,6073,237,8502,681,6764,474,3823,704,7262,165,3662,048,8702,680,4336,954,5894,331,9272,292,0731,834,9252,111,3502,083,220
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
42,668,201
42,817,849
42,821,106
48,070,763
46,875,588
46,309,846
45,748,241
45,748,24146,309,84646,875,58848,070,76342,821,10642,817,84942,668,2010000000000000000000000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
4,909,730
5,054,752
6,036,319
5,876,407
5,728,407
5,346,823
5,770,060
6,057,279
5,999,132
31,990,799
30,351,410
29,701,711
31,716,791
30,406,203
31,648,818
31,736,077
0
0
0
0
000031,736,07731,648,81830,406,20331,716,79129,701,71130,351,41031,990,7995,999,1326,057,2795,770,0605,346,8235,728,4075,876,4076,036,3195,054,7524,909,730000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-31,000,000
-31,400,000
-33,511,000
-30,000,000
-559,041
1,466,450
-1,355,344
37,630,534
41,822,038
41,033,842
0
041,033,84241,822,03837,630,534-1,355,3441,466,450-559,041-30,000,000-33,511,000-31,400,000-31,000,000000000000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
00000010000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,340,090
5,196,411
7,498,838
0
0
0
0
0
0
0000007,498,8385,196,4114,340,09000000000000000000000
> Total Stockholder Equity
48,767,978
49,031,477
48,323,448
47,784,959
48,722,790
48,238,937
47,721,395
46,462,869
46,609,992
46,324,159
44,049,242
43,550,540
45,966,555
47,257,433
47,170,003
51,512,681
53,146,626
61,635,473
511,003,487
535,853,596
540,219,576
549,703,501
538,458,228
531,967,689
530,037,901
533,992,428
534,021,181
523,666,623
518,275,877
518,275,877523,666,623534,021,181533,992,428530,037,901531,967,689538,458,228549,703,501540,219,576535,853,596511,003,48761,635,47353,146,62651,512,68147,170,00347,257,43345,966,55543,550,54044,049,24246,324,15946,609,99246,462,86947,721,39548,238,93748,722,79047,784,95948,323,44849,031,47748,767,978
   Common Stock
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
5,277,027
7,900,172
7,900,172
7,900,172
7,900,172
7,900,172
7,900,172
7,900,172
0
0
0
0
00007,900,1727,900,1727,900,1727,900,1727,900,1727,900,1727,900,1725,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,0275,277,027
   Retained Earnings 
7,202,191
7,465,690
6,757,661
6,219,172
7,157,003
6,673,150
6,545,608
5,289,278
5,434,205
5,148,372
2,873,455
2,374,753
4,790,768
6,161,754
6,278,229
10,345,986
11,976,672
20,019,004
38,084,549
112,725,377
116,106,242
121,731,527
114,390,940
106,292,958
104,030,897
106,978,547
108,821,512
97,848,643
0
097,848,643108,821,512106,978,547104,030,897106,292,958114,390,940121,731,527116,106,242112,725,37738,084,54920,019,00411,976,67210,345,9866,278,2296,161,7544,790,7682,374,7532,873,4555,148,3725,434,2055,289,2786,545,6086,673,1507,157,0036,219,1726,757,6617,465,6907,202,191
   Capital Surplus 
0
0
0
0
0
0
0
0
0
36,288,760
36,288,760
36,288,760
36,288,760
36,288,760
36,288,760
36,288,760
36,350,560
36,350,560
543,503,185
493,516,992
493,539,847
493,441,385
493,513,196
493,403,717
493,403,717
0
0
0
0
0000493,403,717493,403,717493,513,196493,441,385493,539,847493,516,992543,503,18536,350,56036,350,56036,288,76036,288,76036,288,76036,288,76036,288,76036,288,76036,288,760000000000
   Treasury Stock0000000000-78,699,086000000000000000000
   Other Stockholders Equity 
0
0
0
0
0
0
-390,000
-392,196
-390,000
-390,000
-390,000
-390,000
-390,000
-470,108
-674,013
-399,092
-457,632
-11,118
45,404
287,768
1,491,528
5,350,169
1,373,671
2,000,038
1,976,380
0
0
0
0
00001,976,3802,000,0381,373,6715,350,1691,491,528287,76845,404-11,118-457,632-399,092-674,013-470,108-390,000-390,000-390,000-390,000-390,000-392,196-390,000000000



6.3. Balance Sheets

Currency in KRW. All numbers in thousands.




6.4. Cash Flows

Currency in KRW. All numbers in thousands.




6.5. Income Statements

Currency in KRW. All numbers in thousands.


6.6. Latest Income Statement

Income Statement (annual), 2023-12-31. Currency in KRW. All numbers in thousands.

Gross Profit (+$)
totalRevenue187,544,189
Cost of Revenue-132,408,805
Gross Profit55,135,38455,135,384
 
Operating Income (+$)
Gross Profit55,135,384
Operating Expense-183,464,845
Operating Income4,079,344-128,329,461
 
Operating Expense (+$)
Research Development24,681,276
Selling General Administrative9,760,650
Selling And Marketing Expenses0
Operating Expense183,464,84534,441,926
 
Net Interest Income (+$)
Interest Income806,543
Interest Expense-3,408,551
Other Finance Cost-0
Net Interest Income-2,602,008
 
Pretax Income (+$)
Operating Income4,079,344
Net Interest Income-2,602,008
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-7,463,5644,079,344
EBIT - interestExpense = -3,408,551
-174,010
3,234,541
Interest Expense3,408,551
Earnings Before Interest and Taxes (EBIT)0-4,055,013
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-7,463,564
Tax Provision--7,542,669
Net Income From Continuing Ops79,10579,105
Net Income-174,010
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net02,602,008
 

Technical Analysis of Green Cross Lab Cell Corporation
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Green Cross Lab Cell Corporation. The general trend of Green Cross Lab Cell Corporation is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Green Cross Lab Cell Corporation's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Green Cross Lab Cell Corporation.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is 0/(-1 +1).

  • Between support/resistance: The price is trading between support and resistance lines.

The bullish price targets are: 26,500 < 29,800 < 30,900.

The bearish price targets are: .

Tweet this
Green Cross Lab Cell Corporation Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Green Cross Lab Cell Corporation. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Green Cross Lab Cell Corporation Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Green Cross Lab Cell Corporation. The current macd is -2,216.66660578.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Green Cross Lab Cell Corporation price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Green Cross Lab Cell Corporation. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Green Cross Lab Cell Corporation price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Green Cross Lab Cell Corporation Daily Moving Average Convergence/Divergence (MACD) ChartGreen Cross Lab Cell Corporation Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Green Cross Lab Cell Corporation. The current adx is 33.57.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Green Cross Lab Cell Corporation shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
Green Cross Lab Cell Corporation Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Green Cross Lab Cell Corporation. The current sar is 27,851.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Green Cross Lab Cell Corporation Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Green Cross Lab Cell Corporation. The current rsi is 30.38. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending up: The RSI is trending up. +1
Green Cross Lab Cell Corporation Daily Relative Strength Index (RSI) ChartGreen Cross Lab Cell Corporation Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Green Cross Lab Cell Corporation. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Green Cross Lab Cell Corporation price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Green Cross Lab Cell Corporation Daily Stochastic Oscillator ChartGreen Cross Lab Cell Corporation Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Green Cross Lab Cell Corporation. The current cci is -73.20681081.

Green Cross Lab Cell Corporation Daily Commodity Channel Index (CCI) ChartGreen Cross Lab Cell Corporation Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Green Cross Lab Cell Corporation. The current cmo is -43.94209782.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Green Cross Lab Cell Corporation Daily Chande Momentum Oscillator (CMO) ChartGreen Cross Lab Cell Corporation Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Green Cross Lab Cell Corporation. The current willr is -91.4893617.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Green Cross Lab Cell Corporation Daily Williams %R ChartGreen Cross Lab Cell Corporation Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Green Cross Lab Cell Corporation.

Green Cross Lab Cell Corporation Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Green Cross Lab Cell Corporation. The current atr is 1,349.

Green Cross Lab Cell Corporation Daily Average True Range (ATR) ChartGreen Cross Lab Cell Corporation Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Green Cross Lab Cell Corporation. The current obv is 310,116.

Green Cross Lab Cell Corporation Daily On-Balance Volume (OBV) ChartGreen Cross Lab Cell Corporation Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Green Cross Lab Cell Corporation. The current mfi is 9.49335012.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Green Cross Lab Cell Corporation Daily Money Flow Index (MFI) ChartGreen Cross Lab Cell Corporation Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Green Cross Lab Cell Corporation.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-03DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-07-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-12STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-07-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-07-25MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-07-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-08-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-08-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-09CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-12WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-14STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-08-16DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-08-19CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-20STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-21STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-08-26STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-08-30STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-02STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-09-03CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-09-05CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-09-06STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-11STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-19SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-09-20MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-24STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-09-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-10-14MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-15BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2024-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-17STOCH SHORT EXITThe %K line crosses above the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-21STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-10-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-25CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-10-28MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-10-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-10-31DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-01STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-04STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-11-06CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-11-07STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-08MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-13STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-18STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-19STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-20MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-11-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-27RSI LONG ENTRY SHORT CLOSE30 crossover to upside

6.3. Candlestick Patterns

Green Cross Lab Cell Corporation Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Green Cross Lab Cell Corporation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5030.381
Ma 20Greater thanMa 5029,290.000
Ma 50Greater thanMa 10031,993.000
Ma 100Greater thanMa 20032,067.000
OpenGreater thanClose25,500.000
Total0/5 (0.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Green Cross Lab Cell Corporation with someone you think should read this too:
  • Are you bullish or bearish on Green Cross Lab Cell Corporation? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Green Cross Lab Cell Corporation? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Green Cross Lab Cell Corporation

I send you an email if I find something interesting about Green Cross Lab Cell Corporation.


Comments

How you think about this?

Leave a comment

Stay informed about Green Cross Lab Cell Corporation.

Receive notifications about Green Cross Lab Cell Corporation in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.